Allergy & Asthma Network Joins National Health Council to Strengthen Patient Advocacy
Allergy & Asthma Network is joining a national coalition of nearly 200 health-related organizations united in advancing patient-centered policies.
Allergy & Asthma Network is joining a national coalition of nearly 200 health-related organizations united in advancing patient-centered policies.
Discover the latest oral treatment for chronic spontaneous urticaria and how it can help manage symptoms effectively.
Angel shares his journey living with chronic hives from solar urticaria, highlighting the challenges of treatment access and barriers in Hispanic care.
Emmeka shares her journey with chronic spontaneous urticaria (CSU), navigating invisible hives, beauty routines, and stigma as a Black woman.
Rachell shares her journey with chronic urticaria as a Latina, overcoming stigma and misdiagnosis to build a supportive, trusted care team.
People with autism, especially children, may have difficulty understanding and managing their allergies or asthma.
This webinar was recoded on December 4, 2025 Research indicates that rhinosinusitis affects 5-12% of the global population, and among those with chronic rhinosinusitis, 25-30% also have nasal polyps. Often, rhinosinusitis is accompanied by nasal polyps—benign growths that can obstruct airflow—and asthma often worsens in patients with rhinosinusitis and nasal polyps due to shared inflammatory…
This webinar was recorded on November 19, 2025 Food allergies now affect nearly 8% of children in the United States, with incidence continuing to rise and increasing the risk of comorbid atopic dermatitis, asthma, and allergic rhinitis. Understanding effective prevention and treatment strategies is essential for optimizing patient care. Join us as we discuss current…
Allergy & Asthma Network Director of Advocacy Nissa Shaffi delivered testimony before the U.S. Centers for Disease Control and Prevention (CDC) on the critical issue of vaccine access.
The only way for people with latex allergy to prevent symptoms is strict avoidance of latex. Learn more during Latex Allergy Awareness Week.
This webinar will provide a comprehensive review of best practices for the diagnosis and risk stratification of suspected drug hypersensitivity, with an emphasis on when and how to apply diagnostic testing.
What started as a newsletter, by Nancy Sander, grew into the Allergy & Asthma Network, a leading national nonprofit organization.
End of content
End of content

10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our eNewsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.